UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

JNCI : Journal of the National Cancer Institute, 2005-11, Vol.97 (22), p.1652-1662

2005

Volltextzugriff (PDF)

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

Cancer prevention research (Philadelphia, Pa.), 2010-06, Vol.3 (6), p.696-706

2010

Volltextzugriff (PDF)

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)

American journal of obstetrics and gynecology, 2011-12, Vol.205 (6), p.535.e1-535.e5

2011

Volltextzugriff (PDF)

Recruitment practices for U.S. minority and underserved populations in NRG oncology: Results of an online survey

Contemporary clinical trials communications, 2018-06, Vol.10, p.100-104

2018

Volltextzugriff (PDF)

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

JAMA : the journal of the American Medical Association, 2006-06, Vol.295 (23), p.2727

2006

Volltextzugriff (PDF)

Compliance With Patient-Reported Outcomes in Multicenter Clinical Trials: Methodologic and Practical Approaches

Journal of clinical oncology, 2007-11, Vol.25 (32), p.5113-5120

2007

Volltextzugriff (PDF)

Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials

Cancer prevention research (Philadelphia, Pa.), 2012-04, Vol.5 (4), p.583-592

2012

Volltextzugriff (PDF)

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

JNCI : Journal of the National Cancer Institute, 1998-09, Vol.90 (18), p.1371-1388

1998

Volltextzugriff (PDF)

Health-Related Quality of Life and Tamoxifen in Breast Cancer Prevention: A Report From the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2659-2669

1999

Volltextzugriff (PDF)

Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer

The New England journal of medicine, 1995-11, Vol.333 (22), p.1456-1461

1995

Volltextzugriff (PDF)

Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial

Cancer prevention research (Philadelphia, Pa.), 2011-09, Vol.4 (9), p.1393-1400

2011

Volltextzugriff (PDF)

The Globalization of Cooperative Groups

Seminars in oncology, 2015-10, Vol.42 (5), p.693-712

2015

Volltextzugriff (PDF)

Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR)

Cancer prevention research (Philadelphia, Pa.), 2012-11, Vol.5 (11), p.1321-1329

2012

Volltextzugriff (PDF)

Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14

JNCI : Journal of the National Cancer Institute, 1994-04, Vol.86 (7), p.527-537

1994

Volltextzugriff (PDF)

The Study of Tamoxifen and Raloxifene: Preliminary Enrollment Data from a Randomized Breast Cancer Risk Reduction Trial

Clinical breast cancer, 2002-06, Vol.3 (2), p.153-159

2002

Volltextzugriff (PDF)

The use of tamoxifen and raloxifene for the prevention of breast cancer

Recent results in cancer research, 2009, Vol.181, p.113

2009

Volltextzugriff (PDF)

Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials

Clinical trials (London, England), 2011-10, Vol.8 (5), p.591-600

2011

Volltextzugriff (PDF)

National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ

Clinical cancer research, 2003-01, Vol.9 (1 Pt 2), p.495S-501S

2003

Volltextzugriff (PDF)

The Half Century of Clinical Trials of the National Surgical Adjuvant Breast and Bowel Project

Seminars in oncology, 2008-10, Vol.35 (5), p.522-529

2008

Volltextzugriff (PDF)

Re: Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

JNCI : Journal of the National Cancer Institute, 2002-10, Vol.94 (19), p.1504-1504

2002

Volltextzugriff (PDF)

Abstract A76: Recruitment practices for minority and underserved populations in NRG Oncology: Results of an online survey

Cancer epidemiology, biomarkers & prevention, 2017-02, Vol.26 (2_Supplement), p.A76-A76

2017

Volltextzugriff (PDF)

Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

Obstetrical & gynecological survey, 2006-10, Vol.61 (10), p.650-650

2006

Volltextzugriff (PDF)

Final updated results of the NRG Oncology/NSABP Protocol P-2: Study of Tamoxifen and Raloxifene (STAR) in preventing breast cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.1500-1500

2015

Volltextzugriff (PDF)

Gynecologic Conditions in Participants in the NSABP Study of Tamoxifen and Raloxifene

American journal of obstetrics and gynecology, 2011-06, Vol.205 (6), p.535.e1-535.e5

2011

Volltextzugriff (PDF)

Compliance With Patient-Reported Outcomes in Multicenter Clinical Trials : Methodologic and Practical Approaches: Patient-reported outcomes assessment in cancer trials

Journal of clinical oncology, 2007, Vol.25 (32), p.5113-5120

2007

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(57)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(32)
Humans
(28)
Female
(22)
Oncology
(15)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Middle Aged
(14)
Breast Neoplasms - Prevention & Control
(13)
Adult
(11)
Tamoxifen - Therapeutic Use
(11)
Aged
(10)
Tumors
(8)
Breast Cancer
(7)
Risk
(7)
Antineoplastic Agents, Hormonal - Therapeutic Use
(6)
Breast Neoplasms - Pathology
(6)
Follow-Up Studies
(6)
Raloxifene Hydrochloride - Therapeutic Use
(6)
Risk Factors
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)

Recruitment practices for U.S. minority and underserved populations in NRG oncology: Results of an online survey

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Compliance With Patient-Reported Outcomes in Multicenter Clinical Trials: Methodologic and Practical Approaches

Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Health-Related Quality of Life and Tamoxifen in Breast Cancer Prevention: A Report From the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer

Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial

The Globalization of Cooperative Groups

Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR)

Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14

The Study of Tamoxifen and Raloxifene: Preliminary Enrollment Data from a Randomized Breast Cancer Risk Reduction Trial

The use of tamoxifen and raloxifene for the prevention of breast cancer

Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials

National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ

The Half Century of Clinical Trials of the National Surgical Adjuvant Breast and Bowel Project

Re: Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Abstract A76: Recruitment practices for minority and underserved populations in NRG Oncology: Results of an online survey

Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

Final updated results of the NRG Oncology/NSABP Protocol P-2: Study of Tamoxifen and Raloxifene (STAR) in preventing breast cancer

Gynecologic Conditions in Participants in the NSABP Study of Tamoxifen and Raloxifene

Compliance With Patient-Reported Outcomes in Multicenter Clinical Trials : Methodologic and Practical Approaches: Patient-reported outcomes assessment in cancer trials

Suchergebnisse filtern